GLYZIA MET 50/1000MG TAB 1`S

GLYZIA MET is a combination tablet containing sitagliptin 50mg and metformin HCl 1000mg. This dual-action medication is designed to help manage type 2 diabetes by improving blood sugar control through two complementary mechanisms. Sitagliptin works by increasing insulin release when blood glucose is elevated, while metformin reduces glucose production in the liver and improves insulin sensitivity. Suitable for patients whose diabetes is not adequately controlled with diet and exercise alone or as an adjunct to other antidiabetic agents. Each pack contains 1 tablet. Always follow your healthcare provider's dosage instructions and maintain regular monitoring of blood glucose levels during treatment.